Establishing secure connection…Loading editor…Preparing document…

Healthcare Study Release Form

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

HEALTHCARE STUDY RELEASE FORM

This Healthcare Study Release Form documents the voluntary agreement of the Participant to participate in the research study described below, and authorizes the release and use of specified protected health information and related materials by the named healthcare providers and study personnel. By signing this form the Participant acknowledges having received information about the study, the risks and benefits, and the privacy protections described herein, and agrees to the release provisions subject to the limitations stated.

Participant Information

Date of Birth:     Gender:

Insurance Information

Medical History (Relevant)

Study Information

Study Title:

Principal Investigator:

Expected Start Date:     Expected End Date:

Risks, Benefits, and Alternatives

The Participant has been informed of the reasonably foreseeable risks, discomforts, and possible adverse events associated with participation in this study, which may include clinical risks specific to the procedures described above. The Participant has been informed of potential benefits, if any, and that direct medical benefit is not guaranteed. Alternatives to participation, including standard care options, have been explained.

I acknowledge that the risks and benefits have been explained to me and that I have had the opportunity to ask questions: I acknowledge

Authorization to Release Protected Health Information

I authorize the release of my protected health information (PHI) and other study-related materials as indicated below to the Principal Investigator, study staff, sponsor representatives, and regulatory authorities for purposes of conducting the study, data analysis, monitoring, and regulatory compliance. This authorization includes information created before, on, and after the date of this authorization unless limited below.

Types of information to be released (check all that apply):

Medical records and clinic notes    Laboratory results    Imaging and radiology reports

Pathology reports    Genetic test results    Audio/video recordings and photographs

De-identified data for future research or secondary analysis    Permission to re-contact me for follow-up or future studies

I understand that information released pursuant to this authorization may be subject to re-disclosure by the recipient and may no longer be protected by privacy laws. I authorize re-disclosure for research, regulatory, or publication purposes provided identifiers are removed when required.

Privacy, Confidentiality, and HIPAA Acknowledgment

Study records that include my personal health information will be kept confidential to the extent required by law. Reasonable safeguards will be used to protect the confidentiality of data. The Participant acknowledges receipt of a privacy notice describing permitted uses and disclosures of protected health information related to this study.

I acknowledge that I have been provided information regarding privacy protections and uses of my health information for research purposes.

Withdrawal and Revocation

Participation is voluntary. I may withdraw my consent and stop participating at any time. If I revoke this authorization, I understand that the revocation will not apply to information already used or disclosed in reliance on this authorization prior to the date the revocation is received, and that withdrawal may affect my ability to continue in the study.

To revoke this authorization, I must provide written notice to the Principal Investigator at the contact information below:

Compensation and Costs

Will the participant receive compensation or reimbursement for participation?   Yes    No

Release of Claims and Indemnification

In consideration of being permitted to participate in the Study, and to the fullest extent permitted by applicable law, the Participant releases and discharges the Institution, its employees, agents, investigators, sponsors, and contractors from any and all claims, liabilities, losses, or damages arising directly from the Participant’s participation in the Study, except for claims arising from the gross negligence or willful misconduct of those released parties. This release does not limit the Participant’s right to seek medical care for injury.

Certifications and Participant Acknowledgment

I certify that I am the person named above, that I have read and understand this Healthcare Study Release Form (or it has been read to me), that my questions have been answered to my satisfaction, and that I voluntarily agree to the terms set forth herein. I understand that signing this form does not waive any of my legal rights except as expressly set forth above.

Participant Printed Name:

Relationship (if signing for minor or other):

Signature:

Date:

Participant Contact Phone:

If applicable, Witness Name:

Enter text✕

What the Healthcare Study Release Form Is

A Healthcare Study Release Form is a written authorization that permits a patient or participant to allow a covered entity, provider, or researcher to disclose protected health information (PHI) for a defined research study or clinical investigation. The form specifies the scope of information released, the recipient(s), the purpose of disclosure, effective and expiration dates, and any conditions or limitations on use. It documents informed consent for data sharing, creates a reproducible record for compliance, and supports auditability when retained according to regulatory requirements such as HIPAA and applicable institutional review board (IRB) policies.

Why a Clear Release Form Matters for Research and Compliance

A precise Healthcare Study Release Form protects participant rights, documents consent, and reduces legal and operational friction for study teams. It clarifies permitted uses of PHI, supports IRB review and HIPAA compliance, and helps institutions demonstrate that consent and disclosure conditions were met.

Why a Clear Release Form Matters for Research and Compliance

Who Typically Completes or Relies on This Form

The Healthcare Study Release Form is used by clinical researchers, healthcare staff, and participants whenever PHI is shared for research purposes.

  • Clinical researchers and PIs — Prepare study-specific authorization language, ensure IRB alignment, and collect documented consent from participants.
  • Healthcare providers and records teams — Verify identity, extract requested PHI subsets, and route disclosures according to the release.
  • Study participants and legal guardians — Review the scope, sign to indicate informed consent, and retain a copy for personal records.

Maintaining complete signed forms helps satisfy audit requests, supports lawful data transfers, and reduces delays in study enrollment and data access.

Core Elements Every Professional Release Should Include

A well-constructed Healthcare Study Release Form is concise but complete, balancing participant readability with the legal elements required by HIPAA and IRBs.

Authorization Language

Clear statement authorizing disclosure of PHI and naming the disclosing party, recipient(s), and legal basis for release in plain language for participant understanding.

Scope of PHI

Specific list or categories of information to be released (e.g., dates of service, diagnoses, lab results) to avoid overbroad disclosures and support minimum necessary principles.

Purpose of Use

Concise description of the study purpose and how the data will be used, including any future research or data sharing plans that affect participant consent.

Effective/Expiration

Start and end dates or event-based triggers for authorization termination; include conditions under which the authorization can be revoked prior to the expiration date.

Revocation Instructions

Clear procedure for withdrawing consent, including recipient contact details, how withdrawal affects previously shared data, and any limitations on revocation.

Signature Block

Participant name, signature or e-signature, date, and, if applicable, guardian or legally authorized representative information with their authority described.

Security and Compliance Details to Record

Encryption: TLS 1.2/1.3; AES-256
Audit Trail: Timestamps and IP address
BAA Required: Business Associate Agreement needed
Access Controls: Role-based signer permissions
Data Minimization: Limit PHI to necessary elements
Retention Schedule: Record retention policy noted

Step-by-Step: Completing the Release Form

Follow this sequence to reduce errors and ensure the release meets regulatory and IRB expectations.

  • 01
    Review study details: Confirm study name, sponsor, and purpose before proceeding.
  • 02
    Identify PHI scope: Select specific records or data categories required for the study.
  • 03
    Fill participant details: Enter full legal name, DOB, contact, and required identifiers.
  • 04
    Sign and date: Obtain participant signature and record the effective date.

How a Typical Authorization Workflow Operates

Authorization flows follow a predictable pattern from preparation through secure storage and audit logging.

  • Prepare release: Draft form language consistent with IRB-approved template.
  • Provide to participant: Share via secure portal, paper, or e-sign link with disclosure terms.
  • Authenticate signer: Confirm identity using ID check, account, SMS, or KBA as required.
  • Store securely: Retain signed record and audit trail in restricted storage.

Digital Workflow Settings to Configure

Configure these settings when implementing electronic completion and signature to preserve auditability and access controls.

Field Configuration
Authentication method Email link | SMS code | KBA
Signature type Typed, drawn, or PKI digital
Audit logging Enable IP, timestamp, and event log
Storage location Encrypted cloud repository with access control

Platform and Integration Considerations

Choose a platform that supports HIPAA controls, audit logging, and document export in common formats for recordkeeping.

  • Browser & formats: Support for PDF, DOCX, and mobile browsers
  • Authentication options: Email, SMS, KBA, SSO available
  • Integrations: Connectors for EHRs and cloud storage

Ensure the vendor can sign a Business Associate Agreement for HIPAA workflows, provides AES-256 at-rest encryption and TLS in transit, and produces a verifiable audit trail for each signed release.

Timelines, Deadlines, and What to Expect

Timing expectations vary by study and institution; record and communicate key dates to participants and staff.

Effective date format:

Enter as MM/DD/YYYY; determines when authorization begins.

Withdrawal processing time:

Allow up to 30 days to process participant revocation requests.

Data access requests:

Respond to participant requests for copies within 30 days when applicable.

Study end retention:

Follow institutional retention; longer retention may apply for audit.

IRB reporting windows:

Report adverse events or protocol deviations per IRB schedule.

Common Mistakes to Avoid

  • Using vague language about PHI scope, which can lead to over-disclosure or IRB disapproval and weaken minimum necessary protections.
  • Omitting expiration or revocation instructions, creating uncertainty about how long data sharing remains authorized or how to withdraw consent.
  • Mismatched names or identifiers between the form and medical records, increasing risk that records cannot be matched or are legally invalid.
  • Relying on weak signer authentication for sensitive health data transfers, which can expose the study to HIPAA and institutional compliance concerns.

Penalties and Risks from Incomplete or Improper Releases

HIPAA penalties: Civil and criminal fines possible
Invalid consent: Data unusable for study analysis
Participant harm: Privacy breach increases liability
Regulatory reporting: Mandatory notification and investigation
Enrollment delays: Incomplete forms slow study timelines
Contract risk: Sponsor obligations may be affected

eSignature Pricing and Feature Comparison for Study Releases

Comparison of common eSignature providers and core plan starting prices; signNow is listed first per vendor ordering rules.

signNow DocuSign Adobe Sign PandaDoc HelloSign
Starting Price $8/user/mo $15/user/mo $14/user/mo $19/user/mo $15/user/mo
Free Trial 7-day free trial No No Yes, limited Yes, limited
Bulk Send Yes Yes Yes Yes No
Audit Trail Yes Yes Yes Yes Yes
HIPAA Compliant Yes Yes Yes No No

Frequently Asked Questions About Healthcare Study Release Forms

Answers to common legal, technical, and operational questions to help study teams and participants complete and manage releases correctly.


Need help? Contact support

be ready to get more
Join over 28 million airSlate SignNow users